Loading company…
Riskpilot
← Back to search
Sign in
Get full access
X-ING AS
AS
Active
Org 919631635
I Park Richard Johnsens Gate 4, 4021 Stavanger
Wholesale of pharmaceutical and medical goods · NACE 4646
Est. 2017
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2019
NOK 270K
-77% vs 2018
EBITDA margin
-101.7%
-192% vs 2018
Equity ratio
-11.1%
Financial strength
Net profit 2019
NOK -329K
-244% vs 2018
EBITDA — year on year
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2018
0M
0%
2019
Key figures
Annual report 2019
Revenue
NOK 270K
-77%
EBITDA
NOK -274K
-192%
Net profit
NOK -329K
-244%
Total assets
NOK 590K
+58%
Equity
NOK -65K
-124%
Employees
0
—
Company information
Legal name
X-ING AS
Org number
919631635
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
27. september 2017
Share capital
NOK 5 000 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2019-12-31
Financial year
January – December
Company purpose
Utvikling og produksjon av helseprodukter, engroshandel med helseprodukter, herunder deltagelse i andre selskaper med tilsvarende virksomhet.
Contact
Address
I Park Richard Johnsens Gate 4, 4021 Stavanger
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of pharmaceutical and medical goods
Companies in Stavanger
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
1M
2018
0M
2019
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2018
0M
2019
Income statement
NOK thousands
Item
2018
2019
Revenue
1 148
270
Staff expenses
−19
−0
EBITDA
297
−274
Depreciation & amort.
−0
−0
EBIT
297
−274
Net financials
−1
−55
Profit before tax
296
−329
Tax
68
−0
Net profit
228
−329
Balance sheet
NOK thousands
Item
2018
2019
Total assets
373
590
Equity
278
−65
Long-term debt
0
0
Short-term debt
95
656
Total debt
95
656
Financial ratios
5-year trend
EBITDA margin
-101.7%
This company
15.8%
Market median
-744% vs market
2018
2019
Equity ratio
-11.1%
This company
38.2%
Market median
-129% vs market
2018
2019
Return on equity
-32899900.0%
This company
18.4%
Market median
-178803904% vs market
2018
2019
Net profit margin
-122.0%
This company
8.1%
Market median
-1606% vs market
2018
2019
Asset turnover
0.46×
This company
1.12×
Market median
-59% vs market
2018
2019
Debt / equity
10.01×
This company
0.62×
Market median
-1515% vs market
2018
2019
Annual reports & filings
Annual report 2019
Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
View
PDF
Annual report 2018
Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
RB
Roger Bjørkli
Chairman
2019
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of X-ING AS also hold positions in
0
other companies.
Person
Role here
Other companies
Roger Bjørkli
Chairman
0 companies